Effect of commercial vaginal products on the growth of uropathogenic and commensal vaginal bacteria.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
06 05 2020
Historique:
received: 13 12 2019
accepted: 21 03 2020
entrez: 8 5 2020
pubmed: 8 5 2020
medline: 2 12 2020
Statut: epublish

Résumé

Half of postmenopausal women experience genitourinary syndrome of menopause, for which many use lubricating vaginal products. The effect of vaginal products on uropathogenic and commensal vaginal bacteria is poorly understood. We evaluated the effect of five common vaginal products (KY Jelly, Replens Silky Smooth lubricant, coconut oil, Replens Long-Lasting moisturizer or Trimo-San) on growth and viability of Escherichia coli and Lactobacillus crispatus. Bacteria were co-cultured products alone and in the presence of both vaginal epithelial cells and selected products. Bacterial growth was compared between conditions using an unpaired t-test or ANOVA, as appropriate. All products except for coconut oil significantly inhibited growth of laboratory and clinical strains of Escherichia coli (p < 0.02). Only two products (Replens Long-Lasting moisturizer and Trimo-San) significantly inhibited growth of Lactobacillus crispatus (p < 0.01), while the product Replens Silky Smooth stimulated growth (p < 0.01). Co-culture of selected products in the presence of vaginal epithelial cells eliminated the inhibitory effects of the products on E. coli. In conclusion, in vitro exposure to vaginal moisturizing and lubricating products inhibited growth of Escherichia coli, though the inhibition was mitigated by the presence of vaginal epithelial cells. Lactobacillus crispatus demonstrated less growth inhibition than Escherichia coli.

Identifiants

pubmed: 32376907
doi: 10.1038/s41598-020-63652-x
pii: 10.1038/s41598-020-63652-x
pmc: PMC7203152
doi:

Substances chimiques

Lubricants 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7625

Références

Foxman, B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49, 53–70, https://doi.org/10.1067/mda.2003.7 (2003).
doi: 10.1067/mda.2003.7 pubmed: 12601337
Guglietta, A. Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis. Future Microbiol 12, 239–246, https://doi.org/10.2217/fmb-2016-0145 (2017).
doi: 10.2217/fmb-2016-0145 pubmed: 28262045
den Heijer, C. D., Beerepoot, M. A., Prins, J. M., Geerlings, S. E. & Stobberingh, E. E. Determinants of antimicrobial resistance in Escherichia coli strains isolated from faeces and urine of women with recurrent urinary tract infections. PLoS One 7, e49909, https://doi.org/10.1371/journal.pone.0049909 (2012).
doi: 10.1371/journal.pone.0049909
Schwenger, E. M., Tejani, A. M. & Loewen, P. S. Probiotics for preventing urinary tract infections in adults and children. Cochrane Database Syst Rev, CD008772, https://doi.org/10.1002/14651858.CD008772.pub2 (2015).
Hooton, T. M., Roberts, P. L., Cox, M. E. & Stapleton, A. E. Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med 369, 1883–1891, https://doi.org/10.1056/NEJMoa1302186 (2013).
doi: 10.1056/NEJMoa1302186 pubmed: 24224622 pmcid: 4041367
Czaja, C. A. et al. Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women. J Infect Dis 200, 528–536, https://doi.org/10.1086/600385 (2009).
doi: 10.1086/600385 pubmed: 19586416 pmcid: 3674869
Gupta, K. et al. Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis 178, 446–450 (1998).
doi: 10.1086/515635
Stapleton, A. E. The Vaginal Microbiota and Urinary Tract Infection. Microbiol Spectr 4, https://doi.org/10.1128/microbiolspec.UTI-0025-2016 (2016).
Stapleton, A. E. et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis 52, 1212–1217, https://doi.org/10.1093/cid/cir183 (2011).
doi: 10.1093/cid/cir183 pubmed: 21498386 pmcid: 3079401
Brown, J. M. et al. Motivations for Intravaginal Product Use among a Cohort of Women in Los Angeles. PLoS One 11, e0151378, https://doi.org/10.1371/journal.pone.0151378 (2016).
doi: 10.1371/journal.pone.0151378 pubmed: 26967165 pmcid: 4788422
Edwards, D. & Panay, N. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition? Climacteric 19, 151–161, https://doi.org/10.3109/13697137.2015.1124259 (2016).
doi: 10.3109/13697137.2015.1124259 pubmed: 26707589
Smith-McCune, K. et al. Unexpected Inflammatory Effects of Intravaginal Gels (Universal Placebo Gel and Nonoxynol-9) on the Upper Female Reproductive Tract: A Randomized Crossover Study. PLoS One 10, e0129769, https://doi.org/10.1371/journal.pone.0129769 (2015).
doi: 10.1371/journal.pone.0129769 pubmed: 26177352 pmcid: 4503751
Hu, M., Zhou, T., Dezzutti, C. S. & Rohan, L. C. The Effect of Commonly Used Excipients on the Epithelial Integrity of Human Cervicovaginal Tissue. AIDS Res Hum Retroviruses 32, 992–1004, https://doi.org/10.1089/AID.2016.0014 (2016).
doi: 10.1089/AID.2016.0014 pubmed: 27611224 pmcid: 5067878
Wilkinson, E. M., Laniewski, P., Herbst-Kralovetz, M. M. & Brotman, R. M. Personal and Clinical Vaginal Lubricants: Impact on Local Vaginal Microenvironment and Implications for Epithelial Cell Host Response and Barrier Function. J Infect Dis 220, 2009–2018, https://doi.org/10.1093/infdis/jiz412 (2019).
doi: 10.1093/infdis/jiz412 pubmed: 31539059
Dezzutti, C. S. et al. Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity. PLoS One 7, e48328, https://doi.org/10.1371/journal.pone.0048328 (2012).
doi: 10.1371/journal.pone.0048328 pubmed: 23144863 pmcid: 3492332
Steinberg, B. J. Women’s oral health issues. J Calif Dent Assoc 28, 663–667 (2000).
pubmed: 11324047
Ribet, D. & Cossart, P. How bacterial pathogens colonize their hosts and invade deeper tissues. Microbes Infect 17, 173–183, https://doi.org/10.1016/j.micinf.2015.01.004 (2015).
doi: 10.1016/j.micinf.2015.01.004 pubmed: 25637951
McCowan, R. P., Cheng, K. J., Bailey, C. B. & Costerton, J. W. Adhesion of bacteria to epithelial cell surfaces within the reticulo-rumen of cattle. Appl Environ Microbiol 35, 149–155 (1978).
doi: 10.1128/AEM.35.1.149-155.1978
Gupta, K., Hillier, S. L., Hooton, T. M., Roberts, P. L. & Stamm, W. E. Effects of contraceptive method on the vaginal microbial flora: a prospective evaluation. J Infect Dis 181, 595–601, https://doi.org/10.1086/315267 (2000).
doi: 10.1086/315267 pubmed: 10669343
Schreiber, C. A., Meyn, L. A., Creinin, M. D., Barnhart, K. T. & Hillier, S. L. Effects of long-term use of nonoxynol-9 on vaginal flora. Obstet Gynecol 107, 136–143, https://doi.org/10.1097/01.AOG.0000189094.21099.4a (2006).
doi: 10.1097/01.AOG.0000189094.21099.4a pubmed: 16394051 pmcid: 1380307
Kalyoussef, S. et al. Lactobacillus proteins are associated with the bactericidal activity against E. coli of female genital tract secretions. PLoS One 7, e49506, https://doi.org/10.1371/journal.pone.0049506 (2012).
doi: 10.1371/journal.pone.0049506

Auteurs

Kristin J Hung (KJ)

Vincent Obstetrics and Gynecology Department, Division of Female Pelvic Medicine and Reconstructive Surgery, Massachusetts General Hospital, Boston, MA, United States.
Department of Obstetrics, Gynecology & Reproductive Biology, Harvard Medical School, Boston, MA, United States.

Patricia L Hudson (PL)

Vincent Obstetrics and Gynecology Department, Division of Female Pelvic Medicine and Reconstructive Surgery, Massachusetts General Hospital, Boston, MA, United States.
Vincent Center for Reproductive Biology, Vincent Obstetrics and Gynecology Department, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.

Agnes Bergerat (A)

Vincent Center for Reproductive Biology, Vincent Obstetrics and Gynecology Department, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.

Helai Hesham (H)

Vincent Obstetrics and Gynecology Department, Division of Female Pelvic Medicine and Reconstructive Surgery, Massachusetts General Hospital, Boston, MA, United States.
Vincent Center for Reproductive Biology, Vincent Obstetrics and Gynecology Department, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.

Namit Choksi (N)

Vincent Center for Reproductive Biology, Vincent Obstetrics and Gynecology Department, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.

Caroline Mitchell (C)

Vincent Center for Reproductive Biology, Vincent Obstetrics and Gynecology Department, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. caroline.mitchell@mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH